VR Logo

Glenmark Pharmaceuticals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1977

Chairman: Glenn Saldanha

Managing Director: Glenn Saldanha

Group: Glenmark

Listing: NSE: GLENMARK, BSE: 532296

Headquarters: Mumbai, Maharashtra

Website: www.glenmarkpharma.com

Key Facts

Market cap: R 13,436.85 Cr

Revenue (TTM): R 10,851.52 Cr

Earnings (TTM): R 956.52 Cr

Cash: R 1,111.24 Cr

Total Debt: R 4,868.63 Cr

Promoters' ownership: 46.63%

Liquidity: High

52 Week range: R 161.65 - 573.05

Face value: R1.00

Shares outstanding: 28,21,68,156

10 Years Aggregate:

  • CFO: 9,085.22 Cr
  • EBITDA: 13,000.10 Cr
  • Net Profit: 6,662.14 Cr

Stock Performance

Time Period Glenmark Pharma. S&P BSE Healthcare S&P BSE Mid Cap
YTD-3.55-1.4514.74
1 month-2.291.448.05
3 months-0.773.5419.91
1 Year73.8559.2541.92
3 Years-4.3715.027.72
5 Years-9.406.6115.41
10 Years5.1613.7312.07
As on 02-Mar-2021
Year Glenmark Pharma. S&P BSE Mid Cap S&P BSE Healthcare
202042.7519.8761.45
2019-49.80-3.05-3.55
201816.43-13.31-5.89
2017-33.0648.130.49
2016-3.827.97-12.88
201518.887.4315.06
201445.2754.6947.43